Mark Shapiro, MD, PhD, discusses bosutinib as treatment for patients with CML.
Mark Shapiro, MD, PhD
Advertisement
Articles by Mark Shapiro, MD, PhD
Advertisement
Latest Updated Articles
Dr. Shapiro Discusses Bosutinib in CMLPublished: December 23rd 2013 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
4
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
5